83 related articles for article (PubMed ID: 19309542)
21. The role for osmotic agents in children with acute encephalopathies: a systematic review.
Gwer S; Gatakaa H; Mwai L; Idro R; Newton CR
BMC Pediatr; 2010 Apr; 10():23. PubMed ID: 20398408
[TBL] [Abstract][Full Text] [Related]
22. Cryptococcus neoformans responds to mannitol by increasing capsule size in vitro and in vivo.
Guimarães AJ; Frases S; Cordero RJ; Nimrichter L; Casadevall A; Nosanchuk JD
Cell Microbiol; 2010 Jun; 12(6):740-53. PubMed ID: 20070311
[TBL] [Abstract][Full Text] [Related]
23. Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline.
Qureshi AI; Wilson DA; Traystman RJ
Neurosurgery; 1999 May; 44(5):1055-63; discussion 1063-4. PubMed ID: 10232539
[TBL] [Abstract][Full Text] [Related]
24. Comparison of equiosmolar doses of 10% hypertonic saline and 20% mannitol for controlling intracranial hypertention in patients with large hemispheric infarction.
Su Y; Liu Y; Chen Z; Cui L
Clin Neurol Neurosurg; 2021 Jan; 200():106359. PubMed ID: 33246252
[TBL] [Abstract][Full Text] [Related]
25. Equimolar doses of hypertonic agents (saline or mannitol) in the treatment of intracranial hypertension after severe traumatic brain injury.
Huang X; Yang L; Ye J; He S; Wang B
Medicine (Baltimore); 2020 Sep; 99(38):e22004. PubMed ID: 32957318
[TBL] [Abstract][Full Text] [Related]
26. A pilot study evaluating the effect of mannitol and hypertonic saline solution in the treatment of increased intracranial pressure in 2 cats and 1 dog naturally affected by traumatic brain injury.
Ballocco I; Evangelisti MA; Deiana R; Cubeddu F; Pinna Parpaglia ML; Serra G; Carta G; Manunta ML
J Vet Emerg Crit Care (San Antonio); 2019 Sep; 29(5):578-584. PubMed ID: 31448527
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of mannitol and hypertonic saline in treatment of intracranial hypertension of rabbits].
Liu SQ; Zhang KN; Zheng HX; Mei RH; Zhang X; Ding YM
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 41(2):166-70. PubMed ID: 22499513
[TBL] [Abstract][Full Text] [Related]
28. Hypertonic saline more efficacious than mannitol in lethal intracranial hypertension model.
da Silva JC; de Lima Fde M; Valença MM; de Azevedo Filho HR
Neurol Res; 2010 Mar; 32(2):139-43. PubMed ID: 19309542
[TBL] [Abstract][Full Text] [Related]
29. New trends in hyperosmolar therapy?
Diringer MN
Curr Opin Crit Care; 2013 Apr; 19(2):77-82. PubMed ID: 23385373
[TBL] [Abstract][Full Text] [Related]
30. [Hypertonic saline solution for reduction of intracranial pressure. Are there doubts?].
Theilen H; Ragaller M; Koch T
Anaesthesist; 2007 Apr; 56(4):385-7. PubMed ID: 17370055
[TBL] [Abstract][Full Text] [Related]
31. Challenging the gold standard: should mannitol remain our first-line defense against intracranial hypertension?
Infanti JL
J Neurosci Nurs; 2008 Dec; 40(6):362-8. PubMed ID: 19170304
[TBL] [Abstract][Full Text] [Related]
32. Hyperosmolar therapy in the treatment of severe head injury in children: mannitol and hypertonic saline.
Knapp JM
AACN Clin Issues; 2005; 16(2):199-211. PubMed ID: 15876888
[TBL] [Abstract][Full Text] [Related]
33. Hypertonic saline in elevated intracranial pressure: past, present, and future.
Surani S; Lockwood G; Macias MY; Guntupalli B; Varon J
J Intensive Care Med; 2015 Jan; 30(1):8-12. PubMed ID: 23753247
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
